Zurcher Kantonalbank (Zurich Cantonalbank) Ultragenyx Pharmaceutical Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 17,770 shares of RARE stock, worth $795,207. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,770

Previous 17,770 -0.0%

Holding current value

$795,207

Previous $987,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$40.21 - $59.36 $281 - $415	-7 Reduced 0.04%	17,770 $987,000
Q2 2024 Jul 29, 2024	BUY	$37.42 - $51.61 $3,480 - $4,799	93 Added 0.53%	17,777 $730,000
Q1 2024 Apr 25, 2024	BUY	$43.02 - $53.69 $66,121 - $82,521	1,537 Added 9.52%	17,684 $825,000
Q4 2023 Jan 30, 2024	BUY	$31.73 - $49.19 $63,809 - $98,921	2,011 Added 14.23%	16,147 $772,000
Q3 2023 Oct 25, 2023	BUY	$34.92 - $46.66 $80,036 - $106,944	2,292 Added 19.35%	14,136 $503,000
Q2 2023 Aug 07, 2023	BUY	$37.35 - $52.15 $35,370 - $49,386	947 Added 8.69%	11,844 $546,000
Q1 2023 May 08, 2023	BUY	$36.99 - $48.71 $33,956 - $44,715	918 Added 9.2%	10,897 $436,000
Q4 2022 Feb 01, 2023	BUY	$33.72 - $46.33 $14,331 - $19,690	425 Added 4.45%	9,979 $462,000
Q3 2022 Nov 09, 2022	BUY	$39.96 - $66.14 $43,836 - $72,555	1,097 Added 12.97%	9,554 $396,000
Q2 2022 Aug 09, 2022	SELL	$45.8 - $85.4 $36,182 - $67,466	-790 Reduced 8.54%	8,457 $505,000
Q1 2022 Apr 21, 2022	SELL	$62.2 - $84.4 $61,204 - $83,049	-984 Reduced 9.62%	9,247 $672,000
Q4 2021 Feb 01, 2022	BUY	$73.71 - $87.86 $234,029 - $278,955	3,175 Added 45.0%	10,231 $860,000
Q3 2021 Nov 15, 2021	BUY	$77.92 - $102.4 $1,090 - $1,433	14 Added 0.2%	7,056 $636,000
Q2 2021 Jul 30, 2021	SELL	$92.19 - $115.71 $32,543 - $40,845	-353 Reduced 4.77%	7,042 $671,000
Q1 2021 May 03, 2021	BUY	$106.9 - $167.73 $47,036 - $73,801	440 Added 6.33%	7,395 $842,000
Q4 2020 Jan 28, 2021	BUY	$84.4 - $177.39 $70,220 - $147,588	832 Added 13.59%	6,955 $963,000
Q2 2020 Jul 28, 2020	BUY	$46.91 - $78.22 $60,795 - $101,373	1,296 Added 26.85%	6,123 $479,000
Q1 2020 May 06, 2020	BUY	$33.8 - $62.9 $50,767 - $94,475	1,502 Added 45.17%	4,827 $214,000
Q2 2019 Jul 30, 2019	BUY	$54.93 - $74.36 $11,645 - $15,764	212 Added 6.81%	3,325 $211,000
Q1 2019 Apr 29, 2019	BUY	$39.87 - $69.36 $9,648 - $16,785	242 Added 8.43%	3,113 $216,000
Q3 2018 Nov 09, 2018	BUY	$71.81 - $90.15 $34,684 - $43,542	483 Added 20.23%	2,871 $219,000
Q4 2017 Jan 31, 2018	BUY	$43.54 - $57.32 $38,315 - $50,441	880 Added 58.36%	2,388 $111,000
Q3 2017 Nov 08, 2017	BUY	$49.79 - $66.32 $75,083 - $100,010	1,508	1,508 $80,000

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.13B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Ultragenyx Pharmaceutical Inc. Transaction History